Offer - Urjas Oil for just ₹ 1 X
Jubiglim Trio is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Diabetes. Jubiglim Trio also has some secondary and off-label uses. These are listed below.
The correct dosage of Jubiglim Trio depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Jubiglim Trio are Nausea or vomiting, Diarrhoea, Headache. Apart from the aforementioned side effects, Jubiglim Trio can also lead to other problems, which have been listed below. These side effects of Jubiglim Trio are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Jubiglim Trio has a Unknown effect for pregnant women and Safe effect on lactating mothers. Warnings related to Jubiglim Trio's effects on the liver, heart and kidney, if any, have been listed below.
Jubiglim Trio can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Jubiglim Trio in conditions like Liver Disease, Kidney Disease.
Additionally, Jubiglim Trio may also adversely react with other medicines. See below for a complete list.
You should also be aware that Jubiglim Trio is not safe while driving, and is not addiction.
Jubiglim Trio is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Jubiglim Trio safe for pregnant women?
No research has not been done till date on the safety of Jubiglim Trio for pregnant women. So its effects on pregnant women are unknown.
Is the use of Jubiglim Trio safe during breastfeeding?
Jubiglim Trio does not show any harmful effects in lactating women.
What is the effect of Jubiglim Trio on the Kidneys?
Jubiglim Trio may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Jubiglim Trio on the Liver?
You may experience side effects on your liver after taking Jubiglim Trio. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Jubiglim Trio on the Heart?
Very few cases of side effects of Jubiglim Trio on the heart have been reported.
Jubiglim Trio should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Jubiglim Trio unless your doctor advises you to do so -
Is this Jubiglim Trio habit forming or addictive?
No, there is no any evidence that Jubiglim Trio is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Jubiglim Trio can make you feel drowsy.
Is it safe?
Yes, but take Jubiglim Trio only as per medical advice.
Is it able to treat mental disorders?
No, Jubiglim Trio cannot treat any kind of mental disorder.
Interaction between Food and Jubiglim Trio
Due to a lack of research, nothing can be said about the consequences of taking Jubiglim Trio together with food.
Interaction between Alcohol and Jubiglim Trio
No research has been done on this till date. Therefore, it is not known what the effect of taking Jubiglim Trio with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033